{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:03:54Z","timestamp":1790334234346,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.dmd.2026.100382","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:24:33Z","timestamp":1785281073000},"page":"100382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Current evidence supporting solanidine and its metabolites as biomarkers of CYP2D6 activity"],"prefix":"10.1016","volume":"54","author":[{"given":"Deborah","family":"Montmeat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Priscille","family":"Trouvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0710-1659","authenticated-orcid":false,"given":"Cl\u00e9ment","family":"Delage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Borderie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4622-2413","authenticated-orcid":false,"given":"Matthieu","family":"Lilamand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Decl\u00e8ves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0142-0210","authenticated-orcid":false,"given":"Th\u00e9odore","family":"Decaix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.dmd.2026.100382_bib1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.dmd.2026.100382_bib2","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1080\/17425255.2022.2160317","article-title":"CYP2D6 pharmacogenetics and phenoconversion in personalized medicine","volume":"18","author":"Nahid","year":"2022","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"21","key":"10.1016\/j.dmd.2026.100382_bib3","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMra032424","article-title":"Drug metabolism and variability among patients in drug response","volume":"352","author":"Wilkinson","year":"2005","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.dmd.2026.100382_bib4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/clpt.2014.83","article-title":"Geneva cocktail for cytochrome p450 and P-glycoprotein activity assessment using dried blood spots","volume":"96","author":"Bosilkovska","year":"2014","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.dmd.2026.100382_bib5","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.3390\/jpm12111869","article-title":"Cytochromes P450 and p-glycoprotein phenotypic assessment to optimize psychotropic pharmacotherapy: a retrospective analysis of four years of practice in psychiatry","volume":"12","author":"Delage","year":"2022","journal-title":"J Pers Med"},{"issue":"2","key":"10.1016\/j.dmd.2026.100382_bib6","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/sj.clpt.6100050","article-title":"Appropriate phenotyping procedures for drug metabolizing enzymes and transporters in humans and their simultaneous use in the \"cocktail\" approach","volume":"81","author":"Fuhr","year":"2007","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.dmd.2026.100382_bib7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/096032718500400209","article-title":"Solanidine is present in sera of healthy individuals and in amounts dependent on their dietary potato consumption","volume":"4","author":"Harvey","year":"1985","journal-title":"Hum Toxicol"},{"issue":"3","key":"10.1016\/j.dmd.2026.100382_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/cts.13768","article-title":"Evaluation of the usefulness of plasma 4\u03b2-hydroxycholesterol concentration normalized by 4\u03b1-hydroxycholesterol for accurate CYP3A phenotyping","volume":"17","author":"Oda","year":"2024","journal-title":"Clin Transl Sci"},{"issue":"1","key":"10.1016\/j.dmd.2026.100382_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmd.2025.100209","article-title":"Assessing hepatic impairment with biomarker-informed physiologically based pharmacokinetic modeling: strengths and limitations of the endogenous biomarker Coproporphyrin I","volume":"54","author":"Witkowski","year":"2026","journal-title":"Drug Metab Dispos"},{"issue":"16","key":"10.1016\/j.dmd.2026.100382_bib10","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.2217\/pgs.14.155","article-title":"Detection of an endogenous urinary biomarker associated with CYP2D6 activity using global metabolomics","volume":"15","author":"Tay-Sontheimer","year":"2014","journal-title":"Pharmacogenomics"},{"issue":"23","key":"10.1016\/j.dmd.2026.100382_bib11","doi-asserted-by":"crossref","first-page":"4708","DOI":"10.1111\/bph.15651","article-title":"Metabolomics reveals biomarkers in human urine and plasma to predict cytochrome P450 2D6 (CYP2D6) activity","volume":"178","author":"Magliocco","year":"2021","journal-title":"Br J Pharmacol"},{"issue":"10","key":"10.1016\/j.dmd.2026.100382_bib12","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1124\/dmd.122.000957","article-title":"Isolation and identification of 3,4-Seco-Solanidine-3,4-dioic acid (SSDA) as a urinary biomarker of cytochrome P450 2D6 (CYP2D6) activity","volume":"50","author":"Behrle","year":"2022","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.dmd.2026.100382_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40246-024-00579-8","article-title":"Solanidine is a sensitive and specific dietary biomarker for CYP2D6 activity","volume":"18","author":"Kiiski","year":"2024","journal-title":"Hum Genomics"},{"issue":"2","key":"10.1016\/j.dmd.2026.100382_bib14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/cpt.3106","article-title":"Nutrimetric validation of solanidine as dietary-derived CYP2D6 activity marker in vivo","volume":"115","author":"M\u00fcller","year":"2024","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.dmd.2026.100382_bib15","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/cpt.3380","article-title":"Solanidine metabolites as diet-derived biomarkers of CYP2D6-mediated tamoxifen metabolism in breast cancer patients","volume":"116","author":"Medwid","year":"2024","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.dmd.2026.100382_bib16","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00228-023-03462-y","article-title":"Prediction of CYP2D6 poor metabolizers by measurements of solanidine and metabolites-a study in 839 patients with known CYP2D6 genotype","volume":"79","author":"Wollmann","year":"2023","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.dmd.2026.100382_bib17","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/bcp.15721","article-title":"Evidence for solanidine as a dietary CYP2D6 biomarker: significant correlation with risperidone metabolism","volume":"90","author":"Wollmann","year":"2024","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"10.1016\/j.dmd.2026.100382_bib18","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1002\/bcp.70184","article-title":"Solanidine analysis during therapeutic drug monitoring revealed rare CYP2D6 poor metabolizer genotype: a case report","volume":"91","author":"St\u00f8rset","year":"2025","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.dmd.2026.100382_bib19","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/bcp.70004","article-title":"Solanidine-derived CYP2D6 phenotyping elucidates phenoconversion in multimedicated geriatric patients","volume":"91","author":"Sar\u00f6mba","year":"2025","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.dmd.2026.100382_bib20","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/cts.12692","article-title":"Standardizing CYP2D6 genotype to phenotype translation: consensus recommendations from the clinical pharmacogenetics implementation consortium and dutch pharmacogenetics working group","volume":"13","author":"Caudle","year":"2020","journal-title":"Clin Transl Sci"},{"issue":"4","key":"10.1016\/j.dmd.2026.100382_bib21","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3390\/foods9040416","article-title":"Liquid chromatography mass spectrometry quantification of \u03b1-solanine, \u03b1-chaconine, and solanidine in potato protein isolates","volume":"9","author":"Nielsen","year":"2020","journal-title":"Foods"},{"issue":"8","key":"10.1016\/j.dmd.2026.100382_bib22","article-title":"Risk assessment of glycoalkaloids in feed and food, in particular in potatoes and potato-derived products","volume":"18","author":"Schrenk","year":"2020","journal-title":"EFSA J"},{"issue":"5","key":"10.1016\/j.dmd.2026.100382_bib23","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/00498258209052469","article-title":"Kinetics and retention of solanidine in man","volume":"12","author":"Claringbold","year":"1982","journal-title":"Xenobiotica"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955626006513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955626006513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T10:17:24Z","timestamp":1790331444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955626006513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0090955626006513"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2026.100382","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current evidence supporting solanidine and its metabolites as biomarkers of CYP2D6 activity","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2026.100382","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100382"}}